Date:2/18/2009

euticals $ 6,969 $ 11,174 $ 22,397 $ 31,830 ------------------------------------------------------------------------- ------------------------------------------------------------------------- (Loss) income from continuing operations Nucryst Pharmaceuticals $ 1,295 $ 3,209 $ (2,838) $ (4,771) Other (including corporate costs) (2,519) (2,040) 1,103 1,941 ------------------------------------------------------------------------- (Loss) income from continuing operations $ (1,224) $ 1,169 $ (1,735) $ (2,830) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Consolidated Balance December December Sheets 31, 2008 31, 2007 ------------------------------------------------- Cash and cash equivalents $ 46,768 $ 30,993 Current assets 59,783 51,561 Other assets 17,494 31,826 Current liabilities 9,841 8,461 Shareholders' equity 50,002 56,371 THE WESTAIM CORPORATION Consolidated Statements of Operations, Comprehensive Loss and Deficit (unaudited) ------------------------------------------------------------------------- Three Months Ended Twelve Months Ended December 31 December 31 ------------------ ------------------- (thousands of dollars except per share data) 2008 2007 2008 2007 ------------------------------------------------------------------------- Revenue $ 6,969 $ 11,174 $ 22,397 $ 31,830 Costs Manufacturing 3,577 3,226
'/>"/>

SOURCE Westaim Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. The Westaim Corporation update on status of short-term investments
2. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. Westaim announces 2007 third quarter results
4. Westaim reduces ABCP exposure
5. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
6. Westaim announces 2007 year-end results
7. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
8. Westaim announces 2008 first quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
10. Westaim announces 2008 second quarter results
11. Westaim announces sale of iFire Technology Ltd. assets